Traws Pharma, Inc. - TRAW

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 14, 2026 SCHEDULE 13G/A Ikarian Capital, LLC 9.5% 1,555,423 View
Aug 14, 2026 SCHEDULE 13G/A Neil Shahrestani 9.5% 1,555,423 View
Aug 14, 2026 SCHEDULE 13G Sirenia Capital Management LP 9.9% 6,565,474 View
Aug 14, 2026 SCHEDULE 13G Alex Silverstein 9.9% 6,565,474 View
Aug 14, 2026 SCHEDULE 13G/A Squadron Master Fund LP 0.0% 0 View
Aug 14, 2026 SCHEDULE 13G/A Squadron Capital Management LLC 0.0% 0 View
Aug 14, 2026 SCHEDULE 13G/A Matthew Sesterhenn 0.0% 0 View
Aug 14, 2026 SCHEDULE 13G/A William Blank 0.0% 0 View
Aug 12, 2026 SCHEDULE 13G/A Adage Capital Management, L.P. 4.79% 730,000 View
Aug 12, 2026 SCHEDULE 13G/A Robert Atchinson 4.79% 730,000 View
Aug 12, 2026 SCHEDULE 13G/A Phillip Gross 4.79% 730,000 View
May 15, 2026 SCHEDULE 13G/A Perceptive Advisors LLC 6.1% 979,815 View
May 15, 2026 SCHEDULE 13G/A Joseph Edelman 6.1% 979,815 View
May 15, 2026 SCHEDULE 13G/A Perceptive Life Sciences Master Fund, Ltd. 6.1% 979,815 View
May 15, 2026 SCHEDULE 13G/A Squadron Master Fund LP 6.4% 511,714 View
May 15, 2026 SCHEDULE 13G/A Squadron Capital Management LLC 6.4% 511,714 View
May 15, 2026 SCHEDULE 13G/A Matthew Sesterhenn 6.4% 511,714 View
May 15, 2026 SCHEDULE 13G/A William Blank 6.4% 511,714 View
May 05, 2026 SCHEDULE 13D/A — 7.9% — View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.